6525--Intent to Sole Source: TheraSphere Y-90 Glass Microspheres

The Department of Veterans Affairs intends to award a sole-source, firm-fixed-price contract to Boston Scientific Corporation for the supply of TheraSphere Y-90 Glass Microspheres, a specialized medical device used in selective internal radiation therapy for liver cancer treatment. The contract covers the period from May 1, 2025, through April 30, 2027, with two additional 12-month option periods. This action is justified under FAR 6.302-1, citing that Boston Scientific is the only responsible source capable of fulfilling the requirement due to the unique nature of the product. The contract will support the Ralph H. Johnson Veterans Affairs Medical Center in Charleston, South Carolina, where timely and reliable delivery of these microspheres is critical to ongoing patient care. No competitive solicitation or evaluation factors apply to this procurement, as it is a direct sole-source award; no pricing or cost data are disclosed. The notice requests capability statements by February 20, 2026, for market research purposes only and explicitly states it is not a request for competitive proposals. The contracting authority is the 247-NETWORK Contract Office 7 in Augusta, GA, with LaTerrica Sewell serving as the Contracting Officer. The procurement aligns with NAICS code 325412, encompassing pharmaceutical preparation manufacturing, and adheres to FDA regulatory standards for radiopharmaceuticals. Inspection and acceptance responsibilities lie with the Government at the delivery location, the Ralph H. Johnson VA Medical Center. While no detailed contract clauses, packaging requirements, or security clearances are specified, the contract incorporates standard sole-source acquisition protocols and includes two option periods for potential extension.